VP & Global Medical Lead, Respiratory (IL33)
GSK · 2 Locations · GB
Medical Affairs
–
Not yet analysed
Demand62
Career growth62
Healthcare fit32
Remote potential20
5-year outlook
Executive-tier total compensation with substantial bonus and equity components, though exact figures are not stated. Longevity depends on portfolio performance and the IL33 programme's progression through development and launch.
Clinical license
Not required
Applicant reach
narrow
Seniority
executive
Employment type
–
Date found
2026-10-28
Intelligence details
Flexible work details
- Eligible countries
- United Kingdom
Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.
Why this is worth applying to
Only realistic for physician-executives who already hold senior global or regional medical affairs leadership experience in respiratory or immunology; most clinicians exploring non-clinical careers should treat this as a career horizon marker rather than an application target.
Who should apply
Respiratory or immunology-trained physicians with 10+ years in pharma medical affairs, prior Global/Regional Medical Lead or Medical Director titles, and biologic launch or late-stage development experience; senior PharmDs with equivalent immunology medical affairs track records may also be considered.
CV angle
Lead with asset-level medical leadership — named respiratory/immunology programmes, phase II–III trial contributions, publication and data-generation strategy, and KOL/advisory board engagement. Quantify scope (countries covered, budget, team size, cross-functional partners across clinical development, regulatory, market access, and commercial). Frame clinical credentials as the scientific foundation for strategy, not as practice experience, and evidence governance/compliance fluency in a global matrix.
Skills to highlight
- Global medical strategy and asset lifecycle planning
- Respiratory/immunology and biologic scientific expertise
- KOL and external expert engagement
- Clinical development and evidence generation strategy
- Scientific communications and publications oversight
- Cross-functional leadership across development, regulatory, and commercial
- Medical governance and compliance (PhRMA/ABPI, promotional review)
- Launch readiness and medical affairs capability build
Role summary
A VP-level global medical affairs leadership position at GSK overseeing the medical strategy for an IL33-targeted respiratory biologic, spanning evidence generation, scientific exchange with specialists, publication planning, and cross-functional partnership with clinical development, regulatory, and commercial teams across global markets.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.